CIK 0000064803 · Large accelerated filer
CVS HEALTH Corp
Sign in to watch- Ticker
- CVS
- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 050494040
- Phone
- 4017651500
- Business address
- ONE CVS DR., WOONSOCKET, RI, 02895
- Former names
- CVS CAREMARK CORP, CVS/CAREMARK CORP, CVS CORP, MELVILLE CORP
- Open-market buys, last 90 days
- $2,001,315
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,001,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | Khichi Samrat S. EVP, CPO and General Counsel | Shares withheld for taxes | −6,210 | $75.19 | $467K | 9,750 |
| 2024-02-26 | Shah Prem S EVP and Pres-Pharm, Consumer W | Shares withheld for taxes | −261 | $76.43 | $20K | 43,185.46 |
| 2024-02-26 | Chaguturu Sreekanth K EVP and Chief Medical Officer | Shares withheld for taxes | −355 | $76.43 | $27K | 9,333.98 |
| 2024-02-26 | Havanec Laurie P. EVP and Chief People Officer | Shares withheld for taxes | −6,698 | $76.43 | $512K | 45,183 |
| 2024-02-16 | Shah Prem S EVP and Pres-Pharm, Consumer W | Sale | −29,473 | $76.95 | $2.3M | 39,764.76 |
| 2024-02-12 | Chaguturu Sreekanth K EVP and Chief Medical Officer | Grant or award | +1,926 | 8,645.19 | ||
| 2024-02-12 | Havanec Laurie P. EVP and Chief People Officer | Grant or award | +16,817 | 37,203 | ||
| 2024-02-12 | Clark James David SVP, Cont & Chief Acct Officer | Grant or award | +2,452 | 7,150 | ||
| 2024-02-12 | Shah Prem S EVP and Pres-Pharm, Consumer W | Grant or award | +13,313 | 69,237.76 | ||
| 2024-02-12 | Lynch Karen S President and CEO | Grant or award | +136,640 | 136,640 | ||
| 2023-12-14 | Clark James David SVP, Cont & Chief Acct Officer | Shares withheld for taxes | −122 | $68.48 | $8K | 8,760 |
| 2023-12-07 | Finucane Anne A. Director | Gift | −3,450 | $74.28 | $256K | 7,232.25 |
| 2023-11-30 | Kane Brian A EVP/President, Aetna | Grant or award · Stock Option | +77,017 | $67.95 | $5.2M | 77,017 |
| 2023-11-30 | COWHEY THOMAS F. SVP, Interim CFO | Grant or award | +7,358 | $67.95 | $500K | 60,938 |
| 2023-11-15 | SCHAPIRO MARY L Director | Grant or award · Share Credits | +1,817.23 | $69.13 | $126K | 17,734.54 |
| 2023-11-15 | MILLON JEAN PIERRE Director | Grant or award | +1,925 | $69.13 | $133K | 3,362 |
| 2023-11-15 | Mahoney Michael F Director | Grant or award | +1,817 | $69.13 | $126K | 1,817 |
| 2023-11-15 | LUDWIG EDWARD J Director | Grant or award · Share Credits | +2,422.97 | $69.13 | $167K | 14,522.67 |
| 2023-11-15 | KIRBY J SCOTT Director | Grant or award | +2,422 | $69.13 | $167K | 2,721 |
| 2023-11-15 | Finucane Anne A. Director | Grant or award | +1,925 | $69.13 | $133K | 10,682.25 |
Page 11 of 15 · 283 trades